Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujun Wei

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Frontiers in Psychiatry|April 18, 2022
The Association of P300 Components With Clinical Characteristics and Efficacy of Pharmacotherapy in Alcohol Use DisorderJing Yuan, Changjiang Wu, Li Wu, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 19, 2021
Two-stage mental health survey of first-line medical staff after ending COVID-19 epidemic assistance and isolationLi Xu, Dingyun You, Chengyu Li, et al.
Frontiers in Immunology|September 3, 2025
Ruxolitinib and decitabine plus a busulfan-cyclophosphamide conditioning regimen for relapse prophylaxis in patients with high-risk acute myeloid leukemia or myelodysplastic syndromesYujun Wei, Songhua Luan, Lu Wang, et al.
Frontiers in Immunology|June 1, 2026
CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trialJingwen Tang, Yanan Wen, Tian Yang, et al.
Discover Oncology|November 25, 2025
Overexpression of Sterol Regulatory Element-binding Transcription Factor 2 is associated with an adverse prognosis in cytogenetically normal acute myeloid leukemiaRuoqi Shan, Jiachi Wang, Ping Chen, et al.
Leukemia & Lymphoma|January 5, 2026
Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphomaJiayuan Guo, Meng Li, Linlin Zhang, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Frontiers in Psychiatry|April 18, 2022
The Association of P300 Components With Clinical Characteristics and Efficacy of Pharmacotherapy in Alcohol Use DisorderJing Yuan, Changjiang Wu, Li Wu, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 19, 2021
Two-stage mental health survey of first-line medical staff after ending COVID-19 epidemic assistance and isolationLi Xu, Dingyun You, Chengyu Li, et al.
Frontiers in Immunology|September 3, 2025
Ruxolitinib and decitabine plus a busulfan-cyclophosphamide conditioning regimen for relapse prophylaxis in patients with high-risk acute myeloid leukemia or myelodysplastic syndromesYujun Wei, Songhua Luan, Lu Wang, et al.
Frontiers in Immunology|June 1, 2026
CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trialJingwen Tang, Yanan Wen, Tian Yang, et al.
Discover Oncology|November 25, 2025
Overexpression of Sterol Regulatory Element-binding Transcription Factor 2 is associated with an adverse prognosis in cytogenetically normal acute myeloid leukemiaRuoqi Shan, Jiachi Wang, Ping Chen, et al.
Leukemia & Lymphoma|January 5, 2026
Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphomaJiayuan Guo, Meng Li, Linlin Zhang, et al.
Pageof 6